title: [Survival analysis and prognosis of lung cancer related factors].
abstract: OBJECTIVE
  of non-small cell lung cancer (non a small eelllungeaneer, NSCLC) patients with survival analysis and prognostic factors.
  
  
  METHODS
  The research I our hospital from 2005 to September 2010 on the treatment of 275 cases of clinical data of patients with NSCLC, and its age, pathological type, clinical stage, lymph node micrometastasis on prognosis and treatment Investigation of influence, and to analyze the prognostic factors for patients.
  
  
  RESULTS
  The patients in the family history, clinical stage and other factors after treatment for patients with poor prognostic factors after treatment for patients with poor prognostic factors for survival. The treatment of choice for the greatest impact factor. This group of patients selected surgery plus chemotherpy, chemotherapy + radiotherapy, chemotherapy and symptomatic treatment 4, in the survival rates of patients in the four groups was significantly different (P < 0.05). The patients age, clinical stage, lymph node micrometastasis in pathological type on the prognosis of patients was statistically significant.
  
  
  CONCLUSIONS
  The treatment of non-small cell lung cancer is an important prognostic factor.
authors: Department of Oncology, 422nd Hospital, PLA, Zhanjiang, 524009, China.
authors: Zhi-ming
authors: ZM
authors: Fan
authors: Zhu-gong
authors: ZG
authors: Shu
authors: Jiang-ping
authors: JP
authors: Tan
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002289:Carcinoma, Non-Small-Cell Lung / Q000401:mortality* / Q000473:pathology / Q000628:therapy*; D017024:Chemotherapy, Adjuvant; D062445:Claudin-1; D000529:Complementary Therapies; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000401:mortality* / Q000473:pathology / Q000628:therapy*; D008207:Lymphatic Metastasis / Q000473:pathology; D008297:Male; D008565:Membrane Proteins / Q000378:metabolism*; D008875:Middle Aged; D011379:Prognosis; D018714:Radiotherapy, Adjuvant; D012189:Retrospective Studies; D016019:Survival Analysis; D015996:Survival Rate; D016896:Treatment Outcome
chemical_list: C568108:CLDN1 protein, human; D062445:Claudin-1; D008565:Membrane Proteins